CV: tachycardia, angina, ARRHYTHMIAS, palpitations.
GI: nausea, vomiting, anorexia.
Neuro: anxiety, headache, insomnia, irritability, SEIZURES, tremor.
Dose should be determined by theophylline serum level monitoring. Loading dose should be
↓ or eliminated if theophylline preparation has been used in preceding 24 hr. Aminophylline is 80% theophylline (100 mg aminophylline = 80 mg theophylline). Extended-release (controlled-release, sustained-release) products may be given every 824 hr, depending upon the formulation.
- PO (Adults Healthy, Nonsmoking): Loading dose: 5 mg/kg, followed by 10 mg/kg/day divided every 812 hr (not to exceed 900 mg/day).
- PO (Adults with HF, Cor Pulmonale, or Liver Dysfunction): Loading dose: 5 mg/kg, followed by 5 mg/kg/day divided every 812 hr (not to exceed 400 mg/day).
- PO (Children 1216 yr, Nonsmoking): Loading dose: 5 mg/kg, followed by 13 mg/kg/day divided every 812 hr.
- PO (Children 912 yr, adolescent and adult smokers <50 yr): Loading dose: 5 mg/kg, followed by 16 mg/kg/day divided every 812 hr.
- PO (Children 19 yr): Loading dose: 5 mg/kg, followed by 2024 mg/kg/day divided every 812 hr.
- PO (Infants 6 mo1 yr): Loading dose: 5 mg/kg, followed by 1218 mg/kg/day divided every 68 hr.
- PO (Infants 6 wk6 mo): Loading dose: 5 mg/kg, followed by 10 mg/kg/day divided every 68 hr.
- PO (Neonates up to 6 wk): Loading dose: 4 mg/kg, followed by 4 mg/kg/day divided every 12 hr.
- IV (Adults and Children): See aminophylline monograph for IV doses.
Elixophyllin, Theo-24, Theochron
Therapeutic Classification: bronchodilators
Pharmacologic Classification: xanthines
Absorption: Well absorbed from PO dosage forms; absorption from extended-release dosage forms is slow but complete. IV administration results in complete bioavailability.
Distribution: Widely distributed; does not distribute into adipose tissue.
Metabolism/Excretion: 90% metabolized by the liver to several metabolites (including the active metabolites, caffeine, and 3-methylxanthine); metabolites are renally excreted; 10% excreted unchanged by the kidneys.
Half-life: Premature infants: 2030 hr; Term infants: 1125 hr; Children 14 yr: 3.4 hr; Children 617 yr: 3.7 hr; Adults: 910 hr (↑ in patients >60 yr, patients with HF or liver disease; ↓ in cigarette smokers).
(bronchodilation)
Provided that a loading dose has been given and steady-state blood levels exist.